Q&A: From people avoiding wild birds to farmers protecting their animals, Kent State epidemiologist Dr. Tara Smith shares ...

A Massachusetts biopharma giant is at the center of preparations already underway if bird flu mutates and begins to find ...

ICMR seeks collaboration for H5N1 vaccine development to combat bird flu threat in India, emphasizing preparedness and public ...

No person-to-person spread has been detected, but that doesn’t mean an H5N1 avian influenza pandemic isn’t possible or even ...

While drugmakers are hard at work on the shots, they’re not yet ready to blunt the impact of a potential pandemic.

While the virus hasn’t made a sustained leap into humans, vaccines and treatments are being developed ahead of an outbreak.

The US Department of HHS is awarding the pharmaceutical company Moderna $590 million to continue developing a vaccine to protect against bird flu.

Moderna has been awarded approximately $590 million from the federal government to help speed up the development of an mRNA-based bird flu vaccine, health officials said.

The ICMR has initiated the process of development of an ingenious human vaccine candidate against highly-pathogenic avian influenza (H5N1). The Indian Council of Medical Research (ICMR) has invited ...

Last year, Moderna completed a Phase I/II clinical trial of an investigational influenza vaccine called mRNA-1018, which was tested against H5 and H7 bird flu subtypes. The company said in a Jan ...